AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04935476 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 85 mg PO BID
Description: Placebo oral tablet, twice daily for 21 days.
Study NCT05861791 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl
Description: opioid group receives only fentanyl citrate 1200mcg for continuous infusion drug
Study NCT05861791 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ketorolac tromethamine with nefopam hydrochloride
Description: non-opioid group receives ketorolac tromethamine 150mg with nefopam hydrochloride 100mg for continuous infusion drug
Study NCT06056505 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: partial kidney nephrectomy
Description: surgery for partial nephrectomy
Study NCT05970991 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Online Training (BOLT) for measurement-based care (MBC)
Description: Brief Online Training (BOLT) for measurement-based care (MBC) is a series of 4 interactive, self-paced, online training modules that takes approximately 75 - 120 minutes to complete. Clinicians are trained on the core functions, procedures, and best practice approaches for delivering MBC in the school mental health setting. MBC is the systematic collection of patient-reported data to support collaborative clinical decision-making from intake to termination.
Study NCT05970991 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brief Online Training (BOLT) for measurement-based care (MBC)
Description: Brief Online Training (BOLT) for measurement-based care (MBC) is a series of 4 interactive, self-paced, online training modules that takes approximately 75 - 120 minutes to complete. Clinicians are trained on the core functions, procedures, and best practice approaches for delivering MBC in the school mental health setting. MBC is the systematic collection of patient-reported data to support collaborative clinical decision-making from intake to termination.
Study NCT05970991 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Implicit Bias Reduction and Neutralization Training (VIBRANT)
Description: The Virtual Implicit Bias Reduction and Neutralization Training (VIBRANT) is a brief (45-minute), self-paced, interactive online training module designed to help school-based mental health clinicians understand and manage their implicit bias in clinical interactions.
Study NCT05970991 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Live Post-Training Consultation
Description: Two 1-hour long small group consultation sessions with an expert consultant designed as additional opportunities to support knowledge elaboration and skills generalization.
Study NCT05970991 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Live Post-Training Consultation
Description: Two 1-hour long small group consultation sessions with an expert consultant designed as additional opportunities to support knowledge elaboration and skills generalization.
Study NCT05970991 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Asynchronous Discussion Board
Description: An expert facilitated online Discussion Board for additional opportunities of knowledge clarification, practice reinforcement, and community building to support implementation sustainment.
Study NCT05970991 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Asynchronous Discussion Board
Description: An expert facilitated online Discussion Board for additional opportunities of knowledge clarification, practice reinforcement, and community building to support implementation sustainment.
Study NCT05011513 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07321332
Description: PF-07321332 (tablet)
Study NCT05011513 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritonavir
Description: Ritonavir (capsule)
Study NCT05011513 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (tablet)
Study NCT06056505 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DaVinci Robot
Description: device to perform the surgery for partial nephrectomy (not the intervention of interest)
Study NCT06056505 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DaVinci Robot
Description: device to perform the surgery for partial nephrectomy (not the intervention of interest)
Study NCT06056505 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Innersight 3D software
Description: investigational product to generate the 3D model
Study NCT04712604 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: My Sleep Our Sleep (MSOS) Program
Description: MSOS Program is a weekly one-hour Zoom session that focuses on psychoeducation on sleep health for both patients and their sleep partners.
Study NCT05011513 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (capsule)
Study NCT06420154 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-CD19-CAR-T cells
Description: The subjects received infusions of anti-CD19 CAR-T cells following completion of lymphodepleting preconditioning chemotherapy.~Dosage：1×10\^5 cells/Kg; 3×10\^5 cells/Kg; 1×10\^6 cells/Kg~frequency：single infusion
Study NCT05441722 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise prehabilitation
Description: Exercise on a cycle ergometer 24 hours before chemotherapy infusion.
Study NCT06394427 — intervention group
Intervention type: OTHER
Intervention: cycles of neoadjuvant therapy and duration of waiting for surgery
Description: We intended to explore the cycles of neoadjuvant therapy and duration of waiting for surgery on the perioperative outcomes and long-term prognosis of locally advanced NSCLC in the real world
Study NCT04693481 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nature exposure
Description: Nature exposure has different ways, such as walk in the real nature environment; viewing nature photos. Two main reasons make this study will not use the real nature environment: (1) the limitation of time before or amid the soccer competition; (2) the pandemic situation does not allow people go outside as frequently as before. Therefore, the current study will select some nature photos, which are restorative environments and can restore directed attention to counteract mental fatigue.
Study NCT04979117 — intervention group
Intervention type: DEVICE
Intervention: Superb Microvascular Imaging (SMI) (Toshiba)
Description: to determine whether there is a diagnostic value of SMI in Plantar Fasciitis and whether there is a superiority when compared Power Doppler and Color Doppler modalities.
Study NCT06044857 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68-Ga PSMA11
Description: Will be injected/assessed in line with its FDA label.
Study NCT05725083 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lower thoracic epidural
Description: before induction of anesthesia,first the investigators identify the correct targeted thoracic level. All epidural block will be performed under all aseptic precautions with a 17-gauge Tuohy needle and 19 G flex-tip catheters. Using the loss of resistance to saline technique, catheter will be inserted 4 cm into the epidural space and a suitable test dose will be administered to exclude intravascular or sub-arachnoid injection. Bupivacaine 0.25% of 7.5-12 ml volume will be given bolus through the epidural catheter then continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15ml/h .for breakthrough pain patient controlled analgesia (PCA) using nalbuphine 1 mg bolus , 10 min lockout period . The catheter will be removed under complete aseptic precautions after 48 hrs.
Study NCT05725083 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block
Description: before induction of anasthesia ,highfrequency linear ultrasound probe will be placed in a longitudinal parasagittal orientation 2.5-3 cm lateral to the T9 spinous process. A 21G 10 cm needle will be inserted using an in plane approach. The tip of the needle will be placed into the fascial plane on the deep aspect of the erector spinae muscle.confirmed by visible fluid spread lifting the erector spinae muscle off the bony shadow of the transverse process on ultrasonographic imaging.Then the catheter placement 5cm into the space under the erector spinae muscle and suitable test dose will be administered . Bupivacaine 0.25% of 7.5-12 ml volume will be given bolus through the catheter then continuous infusion of bupivacaine 0.1% will be infused at a rate of 5 ml/h up to 15 ml/h , for breakthrough pain patient controlled analgesia (PCA) using nalbuphine 1mg bolus,10 min lockout period.The catheter will be removed under complete aseptic precautions after 48 hrs.
Study NCT05508412 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CancerPEP
Description: CancerPEP
Study NCT05705063 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LCHF Ketogenic Diet
Description: Low Carbohydrate, Moderate Protein, High Fat Ketogenic Dietary Intervention 6 weeks
Study NCT05664724 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Receives interdisciplinary sessions
Description: Along with usual care, participants receive six interdisciplinary sessions at 2 months and 1 month pre-operatively and 2 weeks, 6 weeks, 3 months, and 6 months post-operatively attended by an orthopedic surgeon, a physiotherapist, a patient navigator, and the patient. The pre-operative interdisciplinary sessions will outline expectations, explore patients' questions and concerns, set expectations for the next interdisciplinary session, and ensure goal congruence between all members of the team.~Along with usual care during the post-operative period, participants will receive interdisciplinary sessions that address safety and medical issues, revisit patient expectations, reinforce care team expectations, focus on a personalized rehabilitation plan, and ensure goal congruence between the various team members.
Study NCT05483491 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KK-LC-1 TCR-T cells
Description: Participants will receive a conditioning regimen consisting of cyclophosphamide and fludarabine. KK-LC-1 TCR-T cells will be administered as a single intravenous infusion.
Study NCT05483491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aldesleukin
Description: Aldesleukin 720,000 IU/kg IV every 8 hours will be preferentially administered as an inpatient within 24 hours after KK-LC-1 TCR-T cell infusion for up to 6 doses; however up to 24 hours may elapse between doses. Aldesleukin dosing will be stopped for aldesleukin-related grade 3 or greater toxicity other than flushing, fever, chills, or hemodynamic changes (tachycardia or hypotension) that respond to crystalloid infusion. Aldesleukin may also be stopped at any time at investigator discretion.
Study NCT04466475 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
Description: Given IV
Study NCT04466475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Given via infusion
Study NCT04466475 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peripheral Blood Stem Cell Transplantation
Description: Undergo PBSC transplantation
Study NCT06242210 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pursed lip
Description: pursed lip breathing technique for group A through videos on smart phones and a brochure given to patients. Each session takes 15-20 minutes until researchers ensure that patients understand how to perform exercises and re-demonstrate them. • Each group applied it twice per day for a period of 4 weeks. Telephone follow-up was used for patients in both groups
Study NCT06242210 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stacked Breathing
Description: The technique will be administered to the patient under supervision for 10 minutes, and the patient will be instructed to use this trained exercise in his daily routine as per needed
Study NCT05936801 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Anterior Chest Compression technique
Description: Baseline treatment given is percussion and vibration in side lying position. The therapist puts one arm across the patient's pectoral region to stabilize or compress the upper chest while the other arm is placed either parallel on the lower chest or abdomen below the xiphoid process. Inspiration is facilitated by the pressure on anterior chest, followed by a hold.~Just as the patient is instructed to cough, the therapist applies a quick force with both arms:~down and back on the upper chest and up and back on the lower chest or abdomen. 3 sessions in a wk would be given on alternate days Baseline treatment given is percussion and vibration in side lying position. It Can be used in both the supine and side lying positions. With the patient in the supine position, the therapist places the heel of one hand inferior to the patient's xiphoid process and below the patient's lower ribs.
Study NCT05936801 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Abdominal Thrust Technique
Description: Baseline treatment given is percussion and vibration in side lying position. It Can be used in both the supine and side lying positions. With the patient in the supine position, the therapist places the heel of one hand inferior to the patient's xiphoid process and below the patient's lower ribs.
Study NCT06145841 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pathogen metagenomic next-generation sequencing
Description: In diagnosing patients with AIDS combined with severe pneumonia and/or sepsis, use pathogen metagenomics technology to detect peripheral blood specimens
Study NCT05179811 — intervention group
Intervention type: PROCEDURE
Intervention: Hypnosis sessions
Description: * Physical examination~* Psychiatric Assessment~* VHI, SF-36, IPQ-R questionnaires~* Standardized voice recording~* 3 Standardized Hypnotherapy sessions~* CGI-I-Patient Questionnaire
Study NCT04561700 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Reporting of sucking patterns captured by Instrumented Bottle
Description: In the intervention group, data on nutritive sucking and feeding cues captured by the Instrumented Bottle will be made available to speech therapists to document the feeding session and provide written recommendations in their weekly report.
Study NCT04561700 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: SHAM_COMPARATOR
Intervention: Control
Description: In the control group, the information captured by the Instrumented Bottle will not be made available to speech therapists and therefore, will not be used to document a feeding session or provide weekly recommendations.
Study NCT05210959 — intervention group
Intervention type: OTHER
Intervention: The Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)
Description: The Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS) is an instrument that assesses the quality and quantity of motor development opportunities available in the home for infants aged 3 to 18 months. In this study, the Turkish version of the AHEMD-IS were constructed. Also, the validity and reliability of this version were examined.
Study NCT06217913 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: wearable device to monitor the blood pressure
Description: Pregnant women began to establish antenatal examination records (usually before 12 weeks of pregnancy), and were enrolled through randomized grouping. Pregnant women in the intervention group were provided with wearable blood pressure monitoring equipment, and ambulate blood pressure monitoring was conducted for at least 2 24 hours per week from 12 weeks of pregnancy until 28 weeks of pregnancy, after which blood pressure monitoring was carried out according to routine antenatal examination.
Study NCT05637216 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losartan 25 milligram capsule
Description: Losartan 25 milligram oral capsule
Study NCT05637216 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 25 milligram oral capsule
Study NCT03692507 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HMB
Description: Patients in the first group (HMB only) will take 3 capsules of HMB by VitaMonk™ (1000mg/capsule) daily (morning, noon, and night) for 5 days prior to surgery.
Study NCT03692507 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein and HMB
Description: Patients in the second group (HMB + protein) will drink 2- 8oz bottles of Ensure Enlive daily (morning and night) for 5 days prior to surgery. Each bottle contains 1500mg of HMB and 20 g of protein.
Study NCT03692507 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ERAS
Description: Patients in the third group (High protein) will drink 2- 8oz bottles of Ensure surgery daily (morning and night) for 5 days prior to surgery. Each bottle contains 18g of protein. and a clear 50g Pre-surgery drink on the day of surgery
Study NCT05943717 — intervention group
Intervention type: DEVICE
Intervention: lung ultrasound and electrical cardiometry
Description: : B-lines of lung ultrasound and the parameters of cardiometry will be measured at the mid-week HD session before starting the session by 30 min then every 30min during HD session for 180 min and then after the end of the session of HD by 30 min and then The specificity and sensitivity of both techniques will be compared to each other
Study NCT04748484 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: KCC Active or inactive
Description: Depending of the randomization, the KCC will be active or inactive, and will provide heat when active, but the patient won't know if the medical device is active or not. The battery charge indicator will work the same whether the device is operating or not.
Study NCT01885676 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PRGF-Endoret
Description: PRGF-Endoret mesotherapy micro injection.
Study NCT01885676 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline Solution
Description: Saline Solution mesotherapy micro injection
Study NCT06411574 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gastric Alimetry
Description: The Gastric Alimetry™ System is intended to record, store, view and process gastric myoelectrical activity as an aid in the diagnosis of various gastric disorders.
Study NCT05205174 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: depth electrodes
Description: The study will be conducted at a single center, in TBI patients requiring neurosurgical intervention in the form of EVD placement. During neurosurgical intervention at the bedside in the Intensive Care Unit (ICU), a single depth electrode will be placed in the brain adjacent to the EVD catheter in the same burr hole. After EVD and depth electrode placement, continuous recording of ECoG activity as well as relevant physiological parameters will be performed for the duration of clinically indicated invasive neuromonitoring in accordance with the standard of care for TBI patients. A single recording station is currently available for data collection, therefore, with an anticipated average recording period of 14 days, the study will take greater than 210 days to complete for a total of 15 patients.
Study NCT05411744 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 1 month Rifapentine, Isoniazid and Vitamin B6
Description: Participants will be treated with one month (4 weeks) of daily Isoniazid, Rifapentine and Vitamin B6.
Study NCT02039869 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Confocal endomicroscopy
Description: The probe allows microscopic evaluation of tissue in real time during endoscopy.
Study NCT02039869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor
Description: Acid suppressing medication (over the counter)
Study NCT02039869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sucralfate
Description: Coating agent for damaged intestinal lining.
Study NCT05626556 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SAVE system
Description: The SAVE system will be implemented in end users' homes. Flood sensors will be installed in the bathroom and kitchen, presence sensors in the living room and bedroom, and the contact sensor will be installed at the entrance door. For the best user experience, the installation of the required software (for the sensors kit and the smartwatch) was done on the users' own smartphones. Thus, at the end of the installation, users will have the Aqara Home System in their homes (5 sensors and a sensor hub), a Samsung smartwatch and a SAVE Sensors Adapter, all of which are connected to a router with unlimited internet access.
Study NCT05858216 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Chlor-Trimeton.
Description: Package dose of Chlor-Trimeton will be administered
Study NCT03957161 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Continuation of ACEi and/or ARBs
Description: Patients will continue or start taking ACEi and/or ARBs
Study NCT05741242 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Personalized Synthetic Long Peptide Vaccine
Description: Personalized Synthetic Long Peptide Vaccine
Study NCT04670991 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: EXATRAC imaging
Description: Exatrac imaging performed before the standard CBCT imaging prior to each chemotherapy session
Study NCT05404269 — intervention group
Intervention type: DEVICE
Intervention: AGC mode
Description: Automated Gas Control mode at Maquet FLOW-i anesthesia machine
Study NCT05411757 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: IBR900 combined with Lenvatinib
Description: IBR900 cell injection: 4.0×10\^9 cells, D1,D3 of each cycle. Lenvatinib: body weight ≥ 60kg, 12mg/qd; body weight \< 60kg, 8mg/qd; administered continuously from D5 of the first cycle
Study NCT05411757 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: IBR900 combined with Bevacizumab
Description: IBR900 cell injection: 4.0×10\^9 cells, D1,D3 of each cycle. Bevacizumab:15mg/kg, D1 of each cycle.